ESID, together with IPOPI, INGID, APSID, ASID, ARAPID, CIS, LASID, SEAPID have worked on a joint statement to provide guidance
in advising patients with primary immunodeficiency under our care in the current COVID-19 context. It is believed that PID patients might be at higher risk for this infection or a more severe course of the disease. Thus, patients with PID need to take extra care.
